Related Experiment Video
Updated: May 17, 2026
07:53
Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
Published on: April 26, 2016
Enhanced apoptotic effect of curcumin loaded solid lipid nanoparticles.
Kakkar Vandita1, Bhushan Shashi, Kumar Guru Santosh
1Department of Pharmaceutics, University Institute of Pharmaceutical Sciences, Panjab University , Chandigarh 160014, India.
Molecular Pharmaceutics
|November 7, 2012
Summary
Solid lipid nanoparticles enhance curcumin's bioavailability and anticancer efficacy. This formulation shows significantly greater cell death induction in cancer cell lines, offering therapeutic potential.
Area of Science:
- Pharmacology
- Nanotechnology
- Cancer Biology
Background:
- Curcumin exhibits potent in vitro anticancer activity but suffers from poor pharmacokinetics and stability, limiting in vivo efficacy.
- Solid lipid nanoparticles (SLNs) offer a promising approach to improve drug delivery and bioavailability.
- Previous work demonstrated significant bioavailability enhancement of curcumin when incorporated into SLNs (C-SLNs).
Purpose of the Study:
- To evaluate the in vitro anticancer efficacy of curcumin-loaded solid lipid nanoparticles (C-SLNs).
- To compare the IC50 values of C-SLNs with free curcumin against various human cancer cell lines.
- To investigate the underlying mechanisms of C-SLNs-induced cancer cell death.
Main Methods:
- Preparation and characterization of curcumin-loaded solid lipid nanoparticles (C-SLNs).
- In vitro cytotoxicity assays using human cancer cell lines (HL-60, A549, PC3) to determine IC50 values.
- Assessment of apoptosis-related markers including caspase activation, cytochrome c release, membrane potential loss, NF-κB activation, and TNF-R upregulation.
Main Results:
- C-SLNs demonstrated a 54-85% reduction in IC50 values compared to free curcumin across tested cancer cell lines.
- C-SLNs induced significantly higher levels of cancer cell death (p < 0.001) via apoptosis.
- Mechanisms of action for C-SLNs included caspase activation, cytochrome c release, loss of membrane potential, NF-κB inhibition, and TNF-R upregulation, similar to free curcumin but with greater potency.
Conclusions:
- C-SLNs exhibit significantly enhanced in vitro anticancer effects compared to free curcumin.
- The improved efficacy is likely due to enhanced solubility and cell permeability of curcumin delivered via SLNs.
- C-SLNs hold great potential as an effective therapeutic strategy for cancer treatment, leveraging improved bioavailability and potency.
